Skip to main content
OpenTrials
Completed

NCT Number: NCT04739657

Clinical Evaluation of A New High-speed and High-resolution Intravascular Ultrasound System

Insight Lifetech Intravascular Ultrasound Diagnostic System (referred to as Insight Lifetech IVUS system below),is a new high-speed and high-resolution device for clearly defining vessel architecture and plaque morphology, providing quantitative and qualitative assessment of coronary arteries. Besides, IVUS has already an established role in guidance and optimization of percutaneous coronary intervention. This study will compare the differences, if any, between the intravascular ultrasound(IVUS) results measured by the two different IVUS diagnostic systems.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Percutaneous Coronary Intervention Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Chronic Total Occlusion of Coronary Artery Coronary Artery Disease Coronary Disease Heart Diseases Left Main Coronary Artery Disease Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The General Hospital of the People's Liberation Army, Beijing, China

Loading trial locations.

About this study

Many studies have reported that IVUS is an accurate method for determining the size of the target vessel undergoing stent implantation , and the optimal stent deployment (complete stent expansion and apposition and lack of edge dissection or other complications after implantation). The novel 60 megahertz(60MHz) high-definition IVUS has evolved as a next-generation IVUS imaging technology to provide higher image resolution than conventional 40 megahertz(40MHz) IVUS but with sufficient imaging depth preserved for the assessment of the entire vessel wall structure.

Insight Lifetech IVUS system includes TrueVision IVUS diagnostic catheter and VivoHeart IVUS diagnostic console. It is a novel device with high speed, high resolution, and high image acquisition rate enabling high-speed pullback imaging up to 10mm/sec.

This study is a prospective, multi-center, randomized, single-blind, controlled study with the primary target of investigating the differences, if any, between IVUS measurement results by the Insight Lifetech IVUS system and Boston Scientific IVUS system, imaging catheter of which was available at 40MHz during the study. Other purposes included analyzing the feasibility of the Insight Lifetech IVUS system's high-speed pullback during the IVUS assessment. A total of 130 patients will be recruited from 5 centers in China.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 18 Years and older;
  • Understand and willing to sign the informed consent form;
  • Clinical evaluation shows that the coronary artery stent implantation and the intravascular ultrasound(IVUS) guidance is required.

Exclusion criteria

  • Unable to understand or unwilling to sign the informed consent form;
  • Clinically diagnosed with severe coronary artery spasms;
  • Contraindicated to percutaneous coronary intervention (PCI);
  • Presence of any other factor that the investigator deems is unsuitable for enrollment or completion of this study.

Treatment and study plan

Insight Lifetech IVUS System

Device

The Insight Lifetech IVUS System is intended for examination of coronary intravascular pathology only, including TrueVision IVUS diagnostic catheter and VivoHeart IVUS diagnostic device. IVUS imaging is used in patients who will undergo percutaneous coronary intervention.

Other names: IVUS diagnostic system

Boston Scientific IVUS System

Device

The Boston Scientific IVUS System is intended for the examination of coronary intravascular pathology only, including Opticross IVUS diagnostic catheter and iLAB IVUS diagnostic device. IVUS imaging is used in patients who will undergo percutaneous coronary intervention.

Other names: IVUS diagnostic system

Primary outcomes

  1. Mean Stent Area in square millimeter(MSA)

    Time frame: estimated 1 month on average, by a third-party corelab IVUS image post-analysis

    Comparison between the MSA measured by the Insight Lifetech Intravascular Ultrasound Diagnositic System and Boston Scientific Intravascular Ultrasound Diagnostic System, including mean relative deviation, confidence interval and standard deviation, as assessed by Bland-Altman analysis and Pearson correlation analysis.

Secondary outcomes

  1. Clear Stent Length in millimeter (CSL)

    Time frame: estimated 1 month on average, by a third-party corelab IVUS image post-analysis

    Comparison between the CSL measured by the Insight Lifetech Intravascular Ultrasound Diagnostic System and Boston Scientific Intravascular Ultrasound Diagnostic System, including mean relative deviation, confidence interval and standard deviation, as assessed by Bland-Altman analysis and Pearson analysis.

  2. Minimal Lumen Area in square millimeter(MLA)

    Time frame: estimated 1 month on average, by a third-party corelab IVUS image post-analysis

    Comparison between the MLA measured by the Insight Lifetech Intravascular Ultrasound Diagnostic System and Boston Scientific Intravascular Ultrasound Diagnostic System, including mean relative deviation, confidence interval and standard deviation, as assessed by Bland-Altman analysis and Pearson analysis.

  3. The rate of detected stent malapposition, tissue prolapse and dissection

    Time frame: estimated 1 month on average, by a third-party corelab IVUS image post-analysis

    Detection rate of poor adherence, tissue prolapse and intercalation, for each system individually, and comparison between the two systems.

  4. Stability of system (questionnaire)

    Time frame: estimated 1week on average, by opeartor's rating on questionaire

    Evaluate the stability of both systems concluded from all enrolled case using questionnaire, including below measures :

    • the stability of IVUS examination ;
    • the usability of system operation;
    • the definition of images.

    For each system in 1., 2., and 3., only one of the following five ratings is given:

    • very stable/convenient/clear images;
    • stable/convenient/clear images, inspection was unaffected;
    • slightly unstable/inconvenient/unclear images, inspection was unaffected;
    • unstable/inconvenient/unclear images, inspection was affected; (in the order of 1./2./3.)
    • N/A.

    and is counted as 1 point for that particular rating. The distribution of the points in rating and how many points each rating individually owns are compared between the systems.

  5. Maneuvering performance of catheter (questionnaire)

    Time frame: estimated 1week on average, by opeartor's rating on questionaire

    Evaluate the maneuvering performance of catheters in the two systems concluded from all enrolled case, including below measures :

    • the pushability
    • the crossability
    • the angiographic visibility

    For each system in 1., 2., and 3., only one of the following five ratings is given:

    • excellent pushability/lesion crossability/visibility;
    • pushing met slight resistance/crossed lesion smoothly/good visibility, inspection was unaffected;
    • pushing met obvious resistance/crossed lesion after attempts/mediocre visibility, inspection was unaffected;
    • too resistant to push/unable to cross lesion/very poor visibility, inspection was affected; (in the order of 1./2./3.)
    • N/A.

    and is counted as 1 point for that particular rating. The distribution of the points in rating and how many points each rating individually owns are compared between the systems.

  6. Device success rate

    Time frame: estimated 1day on average, by intraoperative monitoring

    Device success rate, defined as a valid IVUS image for each system, and comparison between the two systems.

  7. Rate of device-related adverse effects

    Time frame: estimated 1day on average, by intraoperative monitoring

    Rate of device-related adverse effects, for each system individually, and comparison between the two systems.

  8. Rate of thrombosis, diffuse lesion and re-stenosis as discerned by IVUS

    Time frame: estimated 1 month on average, by a third-party corelab IVUS image post-analysis

    Rate of thrombosis, diffuse lesion and re-stenosis discerned by each system individually, and comparison between the two systems.

  9. Rate of plaque rupture and plaque properties as discerned by IVUS

    Time frame: estimated 1 month on average, by a third-party corelab IVUS image post-analysis

    Rates of plaque rupture, lipid-rich plaque, fibrous plaque and calcified plaque, discerned by each system individually, and comparison between the two systems.

Sponsors and collaborators

Lead sponsor

Insight Lifetech Co., Ltd.

Industry

Collaborators

  • Chinese PLA General Hospital
  • Guangdong Provincial People's Hospital
  • Shanghai Zhongshan Hospital
  • The First Affiliated Hospital of Zhengzhou University
  • Zhongda Hospital

Registry information

Official study title

Clinical Evaluation of A New High-speed and High-resolution Intravascular Ultrasound System: A Multi-center Prospective Control Study

Acronym: NEW-IVUS

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Feb 4, 2021
Registry last updated
May 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.